FDA Panel Backs XFG Strain for 2026-27 COVID Vaccine Update (MRNA:NASDAQ)
The advisory vote is meant to help manufacturers prepare doses as XFG and its descendants account for more than half of new U.S. infections.
- On Thursday, the Food and Drug Administration's Vaccine and Related Biological Products Advisory Committee recommended updating fall COVID-19 vaccines to target the dominant XFG variant.
- The XFG variant currently accounts for more than half of all United States COVID-19 cases, with mutations that federal officials said may help the virus evade existing antibodies.
- Eight of nine committee members voted for the update, with Dr. Hana El Sahly, a professor at Baylor College of Medicine, abstaining due to concerns the XFG vaccine data wasn't overwhelmingly better than current formulations.
- The non-binding recommendation now moves to the FDA for final approval, though the agency currently lacks both a permanent vaccine chief and a commissioner, creating uncertainty over who will authorize the updated shots.
- Vaccine manufacturers stated in briefing documents they could produce XFG-targeted shots in time for the 2026-2027 season, while the World Health Organization earlier this month recommended the LP.8.1 strain as an alternative.
11 Articles
11 Articles
Updated COVID-19 Jab Recommended By FDA Panel * 100PercentFedUp.com * by Danielle
A Food and Drug Administration (FDA) advisory panel on Thursday recommended updating COVID-19 jabs this fall to target the “XFG variant.” Eight out of nine panel members voted in favor of the recommendation, while one abstained. FDA advisory panel back to its old ways? Eight out of nine panel members voted in favor of the recommendation, while one abstained. “According to the Centers for Disease Control and Prevention's COVID dashboard, new dat…
FDA panel recommends updating Covid shots to target XFG strain
A Food and Drug Administration advisory panel on Thursday recommended updating this fall’s Covid shots to target the XFG variant, a fast-growing strain nicknamed “stratus.”The recommendation — from the FDA’s Vaccines and Related Biological Products Advisory Committee — is meant to help vaccine makers prepare shots for the fall and winter, when Covid infections typically rise
FDA Advisers Recommend Next COVID-19 Vaccines Target XFG Variant
The Food and Drug Administration’s panel of vaccine advisers on May 28 recommended that the next round of COVID-19 vaccines target the XFG COVID-19 variant. Eight of the nine members of the Vaccines and Related Biological Products Advisory Committee who voted during a meeting said that the next vaccines should be monovalent, or only include one antigen, and that the preferred antigen is XFG. XFG variants, including XFG 1.1, are dominant in the U…
FDA advisers recommend COVID vaccines be updated to target current dominant variant
The U.S. FDA's advisory panel recommended on Thursday that COVID-19 vaccines for 2026-2027 immunization should be updated to target the dominant XFG variant, despite some staff concerns about limited data on currently circulating strains.
Coverage Details
Bias Distribution
- 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
